Stocks Picker Articles

28 Jan 2025 03:28

Stocks in Action

Bank of India: The Bank provides a wide range of banking products and financial services to corporate and retail customers. The bank provides specialized services for businesses (dealing in foreign exchange), NRIs, merchant banking, etc. They also have specialized branches that deal in asset recovery, hi-tech agricultural finance, lease finance and treasury, and small-scale industries. The Bank posted strong results for the quarter ended Q3FY25 with Net Profit for the quarter improving by 35% YoY and 6% QoQ.Operating Profit increased by 23% YoY to Rs.3,703 Cr. Net Interest Income (NII) increased by 11% YoY to Rs.6,070 Cr. Operating Expenses stood at Rs.4,114 Cr for Q3FY25 against Rs.3,653 Cr in Q3FY24 and Rs.4,355 Cr in Q2FY25. On the rations front, NIM (Global) stood at 2.80% in Q3FY25 against 2.85% in Q3FY24 and 2.82% in Q2FY25. Return on Assets (Global) improved by 14 bps YoY to 0.96% in Q3FY25 against 0.82% in Q3FY24. On a sequential basis it improved by 2 bps from 0.94% in Q2FY25. Return on Equity improved by 157 bps at 16.53% in Q3FY25 against 14.96% in Q3FY’24. Cost to Income ratio (Global) stood at 52.63% in Q3FY25 against 54.87% in Q3FY24 and 51.22% in Q2FY25. Slippage ratio stood at 0.19% in Q3FY25 improving from 0.26% in Q3FY24. Credit Cost stood at 0.39% in Q3FY25 against 0.46% in Q3FY24. Yield on Advances (Global) improved by 18 bps YoY to 8.55% in Q3FY25 against 8.37% in Q3FY24 and 8.45% in Q2FY25. Cost of Deposits (Global) stood at 4.96% in Q3FY25 against 4.62% in Q3FY24 and 4.95% in Q2FY25. On asset Quality front, Gross NPA declined by 20.47% YoY. Net NPA declined by 29.07% YoY .GNPA ratio improved by 166 bps from 5.35% in Dec’23 to 3.69% in Dec’24. Net NPA ratio improved by 56 bps from 1.41% in Dec’23 to 0.85% in Dec’24. Provision Coverage Ratio stood at 92.48%. Positive on Bank of India given the strong fundamentals and performance of the company.

Torrent Pharma: The company is one of the leading pharmaceutical companies having presence in Indian and global markets. The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India. The company posted healthy quarterly results for the quarter ended Q3FY25 with a 14% YoY jump in net profit to Rs 503 crore. Revenues rose 3% YoY to Rs 2,809 crore.The chronic division achieved a 14% growth in market share, driven by a strong 16% increase in the Cardiac portfolio. The company gained market share in focus therapies such as Cardiac, Diabetes and Gastro. It Added 200MRs, taking the field force count to 6,200. Domestic growth was aided by 8% price, 1.5% volume and 2.5% new product launches. CNS market growth was weak during the quarter however TRP continued to outperform market. Growth in Brazil market was aided by performance of top brands and recent new launches.Growth in Germany market was impacted by lower sales in OTC segment however momentum continues with tender business. New filings in the US delivered low single digit growth resulting in flat QoQ sales, going forward management targets couple of launches in FY26E. R&D expenses stood at 5.4%. Debt repayments are set to reduce interest costs, while the new tax regime at 25% will take effect from FY26. Positive on Torrent Pharmaceuticals given the strong fundamentals and performance of the company.

Stocks Picker Articles

28 Jan 2025 03:27

*Stocks in News*


*Epigral Ltd:* Net profit at Rs 104 cr vs Rs 49 cr, Revenue at Rs. 645 cr vs Rs 471 cr (YoY) (Positive)

*Tata Steel:* Net Profit At Rs 295.5 Cr Vs Of Rs 550 Cr Loss, Revenue At Rs 53,648.3 Cr Vs Poll Of Rs 52,550 Cr (Positive)

*Kaynes:* Net profit at Rs 66.0 cr vs Rs 45.0 cr, Revenue at Rs. 661 cr vs Rs 509 cr (YoY) (Positive)

*IGL:* Net Profit at Rs 326.55 cr vs poll Rs 476.62 cr, Revenue at Rs. 4146 cr vs Rs 3926 cr (YoY) (Positive)

*Bajaj Housing Finance:* Net Profit at Rs 548 cr vs Rs 437 cr, Revenue at Rs. 933 cr vs Rs 745 cr (YoY) (Positive)

*Arvind Smart Spaces:* Company to develop a mega industrial park in Ahmedabad spread over ~440 acre with a top-line potential of Rs. 1,350 crore (Positive)

*Zen Technologies Ltd:* CRISIL Upgraded the long-term rating on the company's bank facilities from CRISIL A-/ Stable to CRISIL A/ Positive (Positive)

*Ujjivan Small Finance Bank:* Bank received board approval for voluntary transition to universal banking; application to RBI imminent. (Positive)

*V L InfraProjects:* Company announced receiving a significant work order valued at Rs 10.05 Cr From Gujarat Water Infrastructure Ltd. (Positive)

*Tata Power:* Arm TP Solar bags contract worth ₹455 crore to supply 300 MWp ALMM-certified solar modules to Maharashtra State Power Generation Company. (Positive)

*Wipro:* Company secures strategic IT partnership with Friesland Campina for digital transformation. (Positive)

*Greenlam:* Board meeting on Jan 30 to consider bonus shares. (Positive)

*ABSLAMC:* Net profit at Rs 222 cr vs Rs 239 cr, Revenue at Rs. 476 cr vs Rs 513 cr (QoQ) (Neutral)

*Railtel:* Net profit at Rs 65 cr vs Rs 62 cr, Revenue at Rs. 768 cr vs Rs 668 cr (YoY). (Neutral)

*Union Bank:* Net profit at Rs 4604 cr vs Rs 3590 cr, NII at Rs. 9240 cr vs Rs 9168 cr (YoY) (Neutral)

*Federal Bank:* Net profit at Rs 955 cr vs Rs 1022 cr, NII at Rs. 2431 cr vs Rs 2143 cr (YoY) (Neutral)

*JSW Steel:* Net profit at Rs 719 cr vs poll Rs 573 cr, Revenue at Rs. 41,378 cr vs poll Rs 40,545 cr (Neutral)

*Petronet LNG:* Net Profit at Rs 867 cr vs Rs 847 cr, Revenue at Rs. 12,227 cr vs Rs 13,021 cr (QoQ) (Neutral)

*Emami:* Net Profit at Rs 279 cr vs Rs 260.7 cr, Revenue at Rs. 1049.5 cr vs Rs 996.3 cr (YoY) (Neutral)

*Coal India:* Net profit at Rs 8491.2 cr vs Rs 10,291.7 cr, Revenue at Rs. 35,780 cr vs Rs 38,357 cr (YoY) (Neutral)

*Piramal Enterprises:* Net profit at Rs 38.6 cr vs loss of Rs 2377.6 cr, Revenue at Rs. 2448.6 cr vs Rs 2475.6 cr (YoY) (Neutral)

*Maharastra Seamless:* Net profit at Rs 186.06 cr vs Rs 276.16 cr, Revenue at Rs. 1408 cr vs Rs 1431 cr (YoY). (Neutral)

*Sarthak Global:* Company announced the re-appointment of Mr. Sunil Gangrade as a Whole-time Director for three years, starting March 1, 2025. (Neutral)

*Bank of Baroda:* Bank executes business transfer agreement (BTA) with Bank Dhofar to transfer business undertaken by the bank’s Oman branch to Bank Dhofar. (Neutral)

*ITC:* ITC Hotels to list on NSE & BSE on January 29, 2025 (Neutral)

*Ashima Ind:* Company announced the resignation of Mr Bhikhabhai j Shah, Chief Operating Officer, effective date March 15, 2025. (Neutral)

*PayTm:* Nakul Jain resigns as the MD & CEO of Paytm Payments Services. (Neutral)

*Bharat Bijlee Ltd:* Company received a Rs 25.26 Cr demand order from the Office of the Additional Commissioner, CGST & C. EX, Navi Mumbai for alleged GST non-payment on leasehold surrender compensation. (Negative)

*Advance Lifestyle:* Company announced the resignation of Managing Director Sundeep Agarwal, effective January 27, 2025 (Negative)

Stocks Picker Articles

27 Jan 2025 13:46

*Fund Flow Activity:*
27 January 2025 (Rs. In Crs.)

*Turnover: (NSE + BSE)*

*Cash Volume:* 95150.83+ 5336.79 Total: 100487.62
*F&O Volume:* 11309459.38 + 6749837.66 Total: 18059297.04

*Provisional Cash*

*FII/FPI: NET SELL: -5015.46*
(9488.57 – 14,504.03)

*DII: NET BUY: +6642.15*
(16,503.43 – 9861.28)

Stocks Picker Articles

27 Jan 2025 10:02

EPIGRAL Q3

Co. says Epigral's revenue grew 37% in 9MFY25, driven by a 15% sales volume increase in derivatives and high-value products. Derivatives contributed 54% to revenue, up from 44% in 9MFY24.

Growth was fueled by recent projects, with additional contributions expected in FY2026 from the Chlorotoluenes Value Chain.

Capacity expansion in CPVC Resin and Epichlorohydrin is projected to boost volumes from FY2027.

EPIGRAL Q3 HIGHLIGHTS

Sales volume grew 11% YoY, it majorly comes from Derivatives & Specialty business

Capacity utilization stood at 81% in Q3FY25

Realization for Caustic Soda improved in the quarter and for other products it has remained almost same

Revenue stood at 649 Crore, growth of 37% YoY on account volume growth from Derivative products

Revenue contribution from Derivatives & Specialty business increased to 50% in Q3FY25 vs 47% in Q3FY24

EBITDA grew by 49% to 183 Crore vs123 Crore in Q3FY24AC

Stocks Picker Articles

27 Jan 2025 08:40

TCI Q3 Result

NET PROFIT UP 33 % AT 103.6 CR (YOY), DOWN 3 % (QOQ)

REVENUE UP 14 % AT 1147 CR (YOY) ,UP 2 % (QOQ)

EBITDA UP 18 % AT 118.5 CR (YOY),UP 1 %(QOQ)

MARGINS AT 10.33 % V 10 % (YOY), 10.5 % (QOQ)

Stocks Picker Articles

27 Jan 2025 07:50

*Global Equities’ Update*

*Dow Future (US):* 44045, -380.0 points/ -0.85%

*Nasdaq Future (US):* 21246, -528.0 points/ -2.43%

*DAX Future (Germany):* 21335, -166.0 points/ -0.77%

*FTSE Future (UK):* 8433, -56.0 points/ -0.66%

*Hang Seng Future (Hong Kong):* 20251, +147.0 points/ +0.73%

*Nikkei Index (Japan):* 39630, -333.0 points/ -0.83%

Stocks Picker Articles

27 Jan 2025 04:16

*Corporate Actions*

*Dividend*

*27-Jan-25*
TANLA: Interim Dividend - Rs. - 6.00
KEI: Interim Dividend - Rs. - 4.00

*28-Jan-25*
WIPRO: Interim Dividend - Rs. - 6.00
TIPSMUSIC: Interim Dividend - Rs. - 3.00
MANGIND: Interim Dividend - Rs. - 0.01
ZENSARTECH: Interim Dividend - Rs. - 2.00
WENDT: Interim Dividend - Rs. - 30.00

*29-Jan-25*
BPCL: Interim Dividend - Rs. - 5.00
MPSLTD: Interim Dividend - Rs. - 33.00
MINDSPACE: Income Distribution RITES

*30-Jan-25*
ACCELYA: Interim Dividend - Rs. - 50.00
HUDCO: Interim Dividend - Rs. - 2.05
COFORGE: Interim Dividend - Rs. - 19.00
SIEMENS: Dividend - Rs. - 12.00
BALKRISIND: Interim Dividend
TCI: Interim Dividend


*IPO*
Dr. Agarwal's Healthcare: Open: 29-Jan-25; Close: 31-Jan-25

*Buyback*
---

*Bonus*
Technopack Polymers: Bonus Issue 1:1; Ex-Date: 27-Jan-25
Shraddha Prime Projects: Bonus Issue 1:1; Ex-Date: 27-Jan-25
Indraprastha Gas: Bonus Issue 1:1; Ex-Date: 31-Jan-25

*Stock Split*
Mazda: Stock Split From Rs. 10/- to Rs. 2/-; Ex-Date: 28-Jan-25
Kiduja India: Stock Split From Rs. 10/- to Rs. 1/-; Ex-Date: 31-Jan-25
Senco Gold: Stock Split From Rs. 10/- to Rs. 5/-; Ex-Date: 31-Jan-25
JBM Auto: Stock Split From Rs. 2/- to Rs. 1/-; Ex-Date: 31-Jan-25
Mohite Industries: Stock Split From Rs. 10/- to Rs. 1/-; Ex-Date: 31-Jan-25
Rama Phosphates: Stock Split From Rs. 10/- to Rs. 5/-; Ex-Date: 07-Feb-25

*Right Issue*
Camlin Fine Sciences: Open: 17-Jan-25; Close: 27-Jan-24
Dhanlaxmi Bank: Open: 08-Jan-25; Close: 28-Jan-24
Pro Fin Capital Services: Open: 09-Jan-25; Close: 28-Jan-24
California Software: Open: 24-Jan-25; Close: 31-Jan-24
GTT Data Solutions: Open: 27-Jan-25; Close: 04-Feb-24
Harshil Agrotech: Open: 10-Jan-25; Close: 05-Feb-24
Globe Textiles (India): Open: 24-Jan-25; Close: 06-Feb-24
Sharanam Infraproject And Trading: Open: 13-Jan-25; Close: 10-Feb-24
Ultracab (India): Open: 28-Jan-25; Close: 11-Feb-24
Iel: Open: 04-Feb-25; Close: 21-Feb-24

*Open Offer*
Prataap Snacks: Open: 16-Jan-25; Close: 29-Jan-24
Religare Enterprises: Open: 27-Jan-25; Close: 07-Feb-24

Stocks Picker Articles

27 Jan 2025 04:15

- Technowgreen Solutions: Canceled a stock issuance of 3,00,000 equity shares due to unfavorable market conditions.

- Omaxe Ltd: Reorganized its project portfolio and consolidated key assets to streamline operations.

- Sterlite Technologies: Announced a strategic restructuring to enhance focus on fiber optic production.

---

📍 8. Financial, Profitability & Shareholder Updates

- IDFC First Bank: Reported a 53% YoY drop in net profit to ₹339 crore.

- Yes Bank: Achieved a 165% YoY increase in net profit, reaching ₹612 crore.

- Ambuja Exports: Net profit for Q3 declined by 29% YoY, dropping to ₹71.3 crore.

- ICICI Prudential Life Insurance: Saw a 15% increase in revenue, totaling ₹20,000 crore in FY 2024.

- Axis Bank: Reported a stable 5% YoY increase in net profit to ₹4,500 crore.

---

📍 9. Other Notable Developments

- L&T: Received approval for a new infrastructure project worth ₹2,500 crore.

- HDFC Ltd: Announced plans to launch a new range of home loan products targeting millennials.

- Tata Steel: Completed a greenfield steel plant project in Odisha, aimed at reducing carbon emissions.

- Jindal Steel: Signed a partnership agreement with a leading automaker to supply steel for electric vehicles.

- Wipro: Launched a new AI-driven software suite for small and medium businesses.

- Mphasis: Launched a global cloud services platform to target new markets in Asia and Europe.

- Reliance Industries: Introduced a renewable energy initiative to power its petrochemical plants.

- Birla Corporation: Planned the expansion of its cement production capacity in Maharashtra.

Stocks Picker Articles

27 Jan 2025 04:10

Stocks in Action

Piramal pharma: The company is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated products across a domestic and global distribution network. The company operates under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization(CDMO), having a product suite in niche areas, such as Active pharmaceutical ingredients ('APIs'), Finished dosage forms ('FDFs'); Piramal Critical Care, a complex hospital generics(CHG) business in the areas such as inhalation anaesthesia, injectable anaesthesia, pain management etc and India consumer healthcare(ICH) business, selling well-known OTC brands. The company reported a robust performance in Q2FY25 with a staggering 17% YoY increase in revenue to Rs 2,242 cr, a notable EBITDA margin increase of 100 bp to 15%, driven by growth in the CDMO segment and the consumer healthcare sector. PAT grew by 200% YoY to 120 cr, with PAT margins at 9% The upcoming capital expenditure plans of the company are geared towards meeting expected customer demand, particularly in sterile products, with financing sourced through accruals and loans rather than direct customer funding. This reflects the strategic positioning that the company aims to achieve in a competitive market landscape. Going ahead the company has given a conservative guidance of early teen revenue and EBITDA growth due to potential currency fluctuations, one-off costs, and a variable product mix in upcoming quarteRs. Currently the company is working on specialized product offerings and partneRships, including Neoatricon, aimed at improving dosing for infants to reduce erroRs. The company is also focusing on market access strategies for these new products. Additionally the expansion of the Lexington facility is also expected to have a positive impact on the company. The company has committed to achieve revenue of $1.2 Bn revenues with 25% EBITDA margin in CDMO business, US$600 Mn revenues with 25%+ EBITDA margin in CHG verticle and US$200 Mn revenues with double-digit EBITDA margin in the ICH vertical, by FY2030. Positive on Piramal Pharma given the strong fundamentals and performance of the company.

Caplin Point Laborateries : The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to oveRseas market. It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin Point reported a strong performance for the quarter ended Q2FY25 with revenue coming at Rs 483 cr(up 17.1% YoY), EBITDA came at Rs 165 cr(up 20% YoY), PAT came at Rs 131 cr(up 12% YoY) .The Caplin Steriles segment showed strong operating revenues, underpinned by strategic investments in R&D despite some increases in operating expenses due to salary increments and project expenses. The company is focusing on long-term sustainability and scalability with initiatives like developing niche oncology products, peptide formulations for obesity/diabetes, with partnerships for insulin production and biosimilars in China. Caplin Point aims to bolster its business in Latin America with innovative products and is transforming its U.S. operations from a B2B to a B2C model, targeting underserved hospitals and smaller healthcare facilities. Going forward the management is focusing on sustainable growth, using internal accruals for project funding, maintaining sufficient liquidity, and targeting a $100 million revenue goal by FY 27 or FY 28.Positive on Caplin Pont Laborateries given the strong fundamentals and performance of the company.

Stocks Picker Articles

27 Jan 2025 03:55

*Fund Houses Recommendations*


Jefferies on *NTPC:* Maintain Buy on company, target price at Rs 500/Sh (Positive)

Bernstein on *NTPC:* Maintain Outperform on company, target price at Rs 440/Sh (Positive)

CLSA on *NTPC:* Maintain Outperform on company, target price at Rs 459/Sh (Positive)

MS on *IGIL:* Initiate Overweight on Company, target price at Rs 617/Sh (Positive)

MS on *Vishal Megamart:* Initiate Overweight on Company, target price at Rs 161/Sh (Positive)

HSBC on *Torrent Pharma:* Maintain Buy on Company, target price at Rs 4000/Sh (Positive)

GS on *Torrent Pharma:* Maintain Buy on Company, target price at Rs 3925/Sh (Positive)

Macquarie on *United Spirits:* Maintain Underperform on Company, raise target price at Rs 1250/Sh (Positive)

CLSA on *DLF:* Maintain Outperform on Company, target price at Rs 975/Sh (Neutral)

Jefferies on *DLF:* Maintain Buy on Company, target price at Rs 1000/Sh (Neutral)

Citi on *Indus Tower:* Maintain Buy on Company, raise target price at Rs 490/Sh (Positive)

Citi on *Indus Tower:* Maintain Buy on Company, target price at Rs 485/Sh (Positive)

CLSA on *ICICI Bank:* Maintain Outperform on Bank, target price at Rs 1600/Sh (Neutral)

Jefferies on *ICICI Bank:* Maintain Buy on Bank, target price at Rs 1600/Sh (Neutral)

Bernstein on *ICICI Bank:* Maintain Market perform on Bank, target price at Rs 1440/Sh (Neutral)

Nuvama on *ICICI Bank:* Maintain Buy on Bank, target price at Rs 1470/Sh (Neutral)

GS on *Indigo:* Maintain Buy on Company, cut target price at Rs 4650/Sh versus Rs 4800/Sh (Neutral)

Kotak on *Indigo:* Maintain Buy on Company, cut target price at Rs 5100/Sh versus Rs 5200/Sh (Neutral)

UBS on *Indigo:* Maintain Buy on Company, raise target price at Rs 5400/Sh versus Rs 5300/Sh (Neutral)

Jefferies on *IDFC First:* Maintain Buy on Bank, target price at Rs 73/Sh (Neutral)

HSBC on *Shriram Fin:* Maintain Buy on Company, target price at Rs 745/Sh (Neutral)

UBS on *Shriram Fin:* Maintain Buy on Company, cut target price at Rs 700/Sh (Neutral)

Citi on *Shriram Fin:* Maintain Buy on Company, target price at Rs 720/Sh (Neutral)

MS on *Balkrishna:* Maintain Underweight on Company, target price at Rs 2159/Sh (Neutral)

Kotak on *Atul:* Maintain Sell on Company, target price at Rs 5140/Sh (Neutral)

MS on *DLF:* Maintain Equal weight on Company, target price at Rs 910/Sh (Neutral)

Citi on *JSW Steel:* Maintain Sell on Company, target price at Rs 715/Sh (Neutral)

GS on *Laurus Lab:* Maintain Sell on Company, target price at Rs 475/Sh (Neutral)

UBS on *AU Small Bank:* Maintain Neutral on Company, cut target price at Rs 640/Sh (Neutral)

JP Morgan on *AU Small Bank:* Maintain Neutral on Company, cut target price at Rs 625/Sh (Neutral)

Nomura on *AU Small Bank:* Downgrade to Reduce on Bank, cut target price at Rs 500/Sh (Negative)

Citi on *AU Small Bank:* Maintain Sell on Company, cut target price at Rs 625/Sh (Negative)

Kotak on *Laurus Lab:* Maintain Sell on Company, cut target price at Rs 420/Sh (Negative)

Stocks Picker Articles

27 Jan 2025 03:54

*Stocks in News*


*Sharda Cropchem:* Net profit at Rs 31.1 cr vs Rs 4.6 cr, Revenue at Rs. 930 cr vs Rs 630 cr (YoY) (Positive)

*Vishnu Chemicals:* Net profit at Rs 34 cr vs Rs 20 cr, Revenue at Rs. 371 cr vs Rs 303 cr (YoY) (Positive)

*Supriya Lifesciences:* Net profit at Rs 47 cr vs Rs 30 cr, Revenue at Rs. 185 cr vs Rs 140 cr (YoY) (Positive)

*MPS Ltd:* Net profit at Rs 40.7 cr vs Rs 29.7 cr, Revenue at Rs. 186 cr vs Rs 133 cr (YoY) (Positive)

*Vimta Labs:* Net profit at Rs 21.4 cr vs Rs 10 cr, Revenue at Rs. 90 cr vs Rs 74 cr (YoY) (Positive)

*RPG Life:* Net profit at Rs 34.9 cr vs Rs 26.5 cr, Revenue at Rs. 172 cr vs Rs 154 cr (YoY) (Positive)

*Intellect Design:* Net profit at Rs 70.2 cr vs Rs 52.8 cr, Revenue at Rs. 610 cr vs Rs 560 cr (QoQ) (Positive)

*PNGS Gargi:* Net profit at Rs 9.1 cr vs Rs 3.1 cr, Revenue at Rs. 26 cr vs Rs 17 cr (YoY) (Positive)

*Laurus Labs:* Net profit at Rs 93 cr vs Rs 25 cr, Revenue at Rs. 1415 cr vs Rs 1194 cr (YoY) (Positive)

*Bank of India:* Net profit at Rs 2516.7 cr vs Rs 1869.5 cr, NII at Rs. 6070.3 cr vs Rs 5463.5 cr (YoY) (Positive)

*DCB Bank:* Net profit at Rs 151.4 cr vs Rs 126.6 cr, NII at Rs. 543 cr vs Rs 474 cr (YoY) (Positive)

*EMS:* Net profit at Rs 50.5 cr vs Rs 37.3 cr, Revenue at Rs. 245.3 cr vs Rs 199.6 cr (YoY) (Positive)

*Macrotech:* Net Profit at ₹944.8 Cr Vs ₹505.2 Cr, Revenue at ₹4.083 Cr Vs ₹2,930.6 Cr (YoY) (Positive)

*Alkyl Amines:* Net profit at Rs 43.7 cr vs Rs 33.4 cr, Revenue at Rs. 371.0 cr vs Rs 322.0 cr (YoY) (Positive)

*Associated Alcohol:* Net profit at Rs 26.1 cr vs Rs 15.3 cr, Revenue at Rs. 334.0 cr vs Rs 258.0 cr (YoY) (Positive)

*Shakti Pumps:* Net profit at Rs 104.0 cr vs Rs 45.0 cr, Revenue at Rs. 648.7 cr vs Rs 495.6 cr (YoY) (Positive)

*SBFC:* Net profit at Rs 88.0 cr vs Rs 64.0 cr, NII at Rs. 227 cr vs Rs 179 cr (YoY) (Positive)

*Essen Specialty Films:* Net profit at Rs 7.4 cr vs Rs 5.5 cr, Revenue at Rs. 47 cr vs Rs 38 cr (YoY) (Positive)

*Yes Bank:* Net Profit At ₹621.3 Cr Vs ₹231.5 Cr, NII Up 10.2% at ₹2,223.5 Cr Vs ₹2,016.9 Cr (YoY) (Positive)

*Ceigall India:* Company emerges L1 bidder for a NHAI’s project worth ₹864.97 crore (Positive)

*Jubilant Ingrevia:* Commissions New cGMP Facility for Niacinamide, With High Bio-Content at Bharuch, Gujarat (Positive)

*HCL Tech:* Company partners with Salesforce as an Agentforce Partner to boost agentic AI innovation. (Positive)

*Kay Cee Energy:* Company has been awarded a work order by RVNL Valued at Rs 3.89 Cr. (Positive)

*Axiscades Tech:* Company’s subsidiary, announced its new AI-enabled Direct RF and Signal Processing system. (Positive)

*Refex Industries:* Subsidiary of the co. signs first-ever term sheet for 153.7 MW wind power project with Torrent Solar Power in Karnataka. (Positive)

*Lupin:* Company receives USFDA approval to market its generic HIV medications (Positive)

*NTPC Green Energy:* Company’s arm bags 300 MW solar project from NHPC. (Positive)

*IEX:* Company projects over 20% volume growth by the end of FY25. (Positive)

*JSW Steel:* With the BPSL expansion ramp-up, volume stabilization is expected in Q4. (Positive)

*NTPC:* TPC Declares Commercial Operations of Unit 1 (660 MW) Of Khurja STPP (2X660 MW) Of THDC India. (Positive)

*KEC International:* Company bags transmission and distribution orders worth ₹1,445 crore from Power Grid. (Positive)

*Indus Towers:* Company says that cash flow for company is robust and, coupled with significant reduction in debt reduction in third quarter. (Positive)

*Mazdock:* Joint bid for six conventional submarines has been found compliant by the Indian Ministry of Defence (Positive)

*JSW Steel:* Net profit at Rs 719 cr vs poll Rs 573 cr, Revenue at Rs. 41,378 cr vs poll Rs 40,545 cr (Neutral)

*Godrej Cons:* Net profit at Rs 498 cr vs Rs 581 cr, Revenue at Rs. 3769 cr vs Rs 3659 cr (YoY) (Neutral)

*Torrent Pharma:* Net profit at Rs 503 cr vs Rs 443 cr, Revenue at Rs. 2809 cr vs Rs 2732 cr (YoY) (Neutral)

Stocks Picker Articles

25 Jan 2025 09:13

*Q3FY25 Earning Calendar - 25.01.2025*

APTECHT, *BALKRISIND*, CDSL, GAEL, GOCOLORS, *ICICIBANK*, *IDFCFIRSTB*, INDOTHAI, JKCEMENT, *LODHA*, *NTPC*, NTPCGREEN, SBFC, SIYSIL, SPORTKING, TCI, *YESBANK*

*BALKRISIND* YoY
* Revenue expected at Rs 2515 crore versus Rs 2274 crore
* EBITDA expected to be seen at Rs 614 crore versus Rs 540 crore
* EBITDA margin expected to be seen at 24.41% versus 23.77%
* Net profit expected to be seen at Rs 383 crore versus Rs 305 crore

*ICICIBANK* QoQ
* NII expected at Rs 20588 crore versus Rs 20048 crore
* EBIT expected to be seen at Rs 16846 crore versus Rs 16723 crore
* EBIT margin expected to be seen at 81.73% versus 83.42%
* Net profit expected to be seen at Rs 11540 crore versus Rs 11745 crore

*IDFCFIRSTB* QoQ
* NII expected at Rs 4972 crore versus Rs 4788 crore
* EBIT expected to be seen at Rs 1971 crore versus Rs 1961 crore
* EBIT margin expected to be seen at 29.31% versus 30.11%
* Net profit expected to be seen at Rs 426 crore versus Rs 200 crore

*LODHA* YoY
* Revenue expected at Rs 3170 crore versus Rs 2930 crore
* EBITDA expected to be seen at Rs 791 crore versus Rs 882 crore
* EBITDA margin expected to be seen at 24.95% versus 30.12%
* Net profit expected to be seen at Rs 494 crore versus Rs 608 crore

*NTPC* YoY
* Revenue expected at Rs 45441 crore versus Rs 42820 crore
* EBITDA expected to be seen at Rs 12945 crore versus Rs 11362 crore
* EBITDA margin expected to be seen at 28.49% versus 26.53%
* Net profit expected to be seen at Rs 5217 crore versus Rs 5155 crore

*YESBANK* YoY
* NII expected at Rs 2270 crore versus Rs 2016 crore
* EBIT expected to be seen at Rs 995 crore versus Rs 864 crore
* EBIT margin expected to be seen at 30.99% versus 26.91%
* Net profit expected to be seen at Rs 490 crore versus Rs 231 crore


*Q3FY25 Earning Calendar - 27.01.2025*

ABSLAMC, *ACC*, APOLLOPIPE, ASTEC, *ATGL*, AURIONPRO, AWL, BAJAJHFL, *CANBK*, *COALINDIA*, DIAMONDYD, DOLPHIN, EMAMILTD, EPIGRAL, *FEDERALBNK*, *IGL*, INDOFARM, *IOC*, JINDRILL, KAYNES, KRN, LTFOODS, MAHLOG, MAHSEAMLES, NAVKARCORP, NIACL, NITINSPIN, PEL, *PETRONET*, PRUDENT, RAILTEL, REFEX, *SUMICHEM*, SUNDRMFAST, *TATASTEEL*, UDS, *UNIONBANK*, WELSPLSOL, WONDERLA, YATHARTH

*ACC* YoY
* Revenue expected at Rs 2980 crore versus Rs 2732 crore
* EBITDA expected to be seen at Rs 977 crore versus Rs 869 crore
* EBITDA margin expected to be seen at 32.79% versus 31.81%
* Net profit expected to be seen at Rs 512 crore versus Rs 355 crore

*CANBK* YoY
* NII expected at Rs 5681 crore versus Rs 4911 crore
* EBIT expected to be seen at Rs 4312 crore versus Rs 3689 crore
* EBIT margin expected to be seen at 74.81% versus 70.74%
* Net profit expected to be seen at Rs 2564 crore versus Rs 1818 crore

*COALINDIA* YoY
* Revenue expected at Rs 34762 crore versus Rs 36154 crore
* EBITDA expected to be seen at Rs 11743 crore versus Rs 11373 crore
* EBITDA margin expected to be seen at 33.78% versus 31.46%
* Net profit expected to be seen at Rs 8467 crore versus Rs 9069 crore

*IGL* QoQ
* Revenue expected at Rs 3946 crore versus Rs 3697 crore
* EBITDA expected to be seen at Rs 550 crore versus Rs 534 crore
* EBITDA margin expected to be seen at 13.94% versus 14.47%
* Net profit expected to be seen at Rs 355 crore versus Rs 454 crore

*IOC* QoQ
* Revenue expected at Rs 179959 crore versus Rs 174976 crore
* EBITDA expected to be seen at Rs 13762 crore versus Rs 3467 crore
* EBITDA margin expected to be seen at 7.65% versus 1.98%
* Net profit expected to be seen at Rs 3995 crore versus Rs -1326 crore

*PETRONET* QoQ
* Revenue expected at Rs 12593 crore versus Rs 13021 crore
* EBITDA expected to be seen at Rs 1272 crore versus Rs 1200 crore
* EBITDA margin expected to be seen at 10.10% versus 9.21%
* Net profit expected to be seen at Rs 892 crore versus Rs 847 crore

*SUMICHEM* YoY
* Revenue expected at Rs 638 crore versus Rs 542 crore
* EBITDA expected to be seen at Rs 127 crore versus Rs 65 crore
* EBITDA margin expected to be seen at 19.91% versus 12.14%
* Net profit expected to be seen at Rs 104 crore versus Rs 54 crore

Stocks Picker Articles

24 Jan 2025 04:31

Corporate Actions

Dividend

24-Jan-25
MASTEK: Interim Dividend - Rs. - 7.00
WAAREERTL: Interim Dividend - Rs. - 1.00
DCMSHRIRAM: Interim Dividend
VIDHIING: Interim Dividend

27-Jan-25
KEI: Interim Dividend


IPO
Denta Water and Infra Solutions: Open: 22-Jan-25; Close: 24-Jan-25

Buyback
---

Bonus
B. N. Rathi Securities: Bonus Issue 1:1; Ex-Date: 24-Jan-25

Stock Split
Insolation Energy: Stock Split From Rs. 10/- to Rs. 1/-; Ex-Date: 24-Jan-25
B. N. Rathi Securities: Stock Split From Rs. 10/- to Rs. 5/-; Ex-Date: 24-Jan-25
Mazda: Stock Split From Rs. 10/- to Rs. 2/-; Ex-Date: 28-Jan-25
Kiduja India: Stock Split From Rs. 10/- to Rs. 1/-; Ex-Date: 31-Jan-25
Senco Gold: Stock Split From Rs. 10/- to Rs. 5/-; Ex-Date: 31-Jan-25
JBM Auto: Stock Split From Rs. 2/- to Rs. 1/-; Ex-Date: 31-Jan-25
Mohite Industries: Stock Split From Rs. 10/- to Rs. 1/-; Ex-Date: 31-Jan-25
Rama Phosphates: Stock Split From Rs. 10/- to Rs. 5/-; Ex-Date: 07-Feb-25

Right Issue
Pro Fin Capital Services: Open: 09-Jan-25; Close: 24-Jan-24
Camlin Fine Sciences: Open: 17-Jan-25; Close: 27-Jan-24
Dhanlaxmi Bank: Open: 08-Jan-25; Close: 28-Jan-24
California Software: Open: 24-Jan-25; Close: 31-Jan-24
Harshil Agrotech: Open: 10-Jan-25; Close: 05-Feb-24
Globe Textiles (India): Open: 24-Jan-25; Close: 06-Feb-24
Sharanam Infraproject And Trading: Open: 13-Jan-25; Close: 10-Feb-24
Ultracab (India): Open: 28-Jan-25; Close: 11-Feb-24
Iel: Open: 04-Feb-25; Close: 21-Feb-24

Open Offer
Prataap Snacks: Open: 16-Jan-25; Close: 29-Jan-24
Religare Enterprises: Open: 27-Jan-25; Close: 07-Feb-24

Stocks Picker Articles

24 Jan 2025 03:43

*Fund Houses Recommendations*


CLSA on *BPCL:* Upgrade to Hold on company, target price at Rs 270/Sh (Positive)

MS on *BPCL:* Maintain Overweight on Company, target price at Rs 419/Sh (Positive)

Citi on *HPCL:* Maintain Buy on Company, target price at Rs 450/Sh (Positive)

DAM on *Ultratech Cem:* Upgrade to Buy on Company, raise target price at Rs 12550/Sh (Positive)

JP Morgan on *Ultratech Cem:* Maintain Overweight on Company, raise target price at Rs 13470/Sh (Positive)

Jefferies on *Ultratech Cem:* Maintain Buy on Company, raise target price at Rs 13265/Sh (Positive)

GS on *Ultratech Cem:* Maintain Buy on Company, target price at Rs 12580/Sh (Positive)

Equirus on *Ultratech Cem:* Maintain Buy on Company, target price at Rs 13490/Sh (Positive)

Macquarie on *Ultratech Cem:* Maintain Outperform on Company, raise target price at Rs 12705/Sh (Positive)

UBS on *Indus Tower:* Maintain Buy on Company, target price at Rs 425/Sh (Positive)

Citi on *Indus Tower:* Maintain Buy on Company, target price at Rs 485/Sh (Positive)

Investec on *Dixon:* Maintain Buy on Company, target price at Rs 19000/Sh (Positive)

Investec on *Adani Green:* Maintain Buy on Company, target price at Rs 2515/Sh (Positive)

Investec on *Adani Energy:* Maintain Buy on Company, target price at Rs 1352/Sh (Positive)

Jefferies on *HPCL:* Maintain Underperform on Company, cuts target price at Rs 295/Sh (Neutral)

Jefferies on *Nippon AMC:* Maintain Buy on Company, cuts target price at Rs 820/Sh (Neutral)

JP Morgan on *United Spirits:* Maintain Neutral on Company, target price at Rs 1415/Sh (Neutral)

Nuvama on *Ultratech Cem:* Maintain Hold on Company, target price at Rs 11574/Sh (Neutral)

Nomura on *Sona BLW:* Maintain Buy on Company, target price at Rs 626/Sh (Neutral)

Nuvama on *Dr Reddy’s Lab:* Maintain Neutral on Company, cut target price at Rs 1533/Sh versus Rs 1553/Sh (Neutral)

DAM Cap on *Dr Reddy’s Lab:* Maintain Neutral on Company, target price at Rs 1331/Sh (Neutral)

HSBC on *Dr Reddy’s Lab:* Maintain Hold on Company, target price at Rs 1250/Sh (Neutral)

Jefferies on *Dr Reddy’s Lab:* Maintain Underperform on Company, cut target price at Rs 1170/Sh versus Rs 1210/Sh (Negative)

Citi on *Dr Reddy’s Lab:* Maintain Sell on Company, cut target price at Rs 1100/Sh (Negative)

Stocks Picker Articles

24 Jan 2025 03:16

*YESBANK* YoY
* NII expected at Rs 2270 crore versus Rs 2016 crore
* EBIT expected to be seen at Rs 995 crore versus Rs 864 crore
* EBIT margin expected to be seen at 30.99% versus 26.91%
* Net profit expected to be seen at Rs 490 crore versus Rs 231 crore


*Q3FY25 Earning Calendar - 27.01.2025*

ABSLAMC, *ACC*, APOLLOPIPE, ASTEC, *ATGL*, AURIONPRO, AWL, BAJAJHFL, *CANBK*, *COALINDIA*, DIAMONDYD, DOLPHIN, EMAMILTD, EPIGRAL, *FEDERALBNK*, *IGL*, INDOFARM, *IOC*, JINDRILL, KAYNES, KRN, LTFOODS, MAHLOG, MAHSEAMLES, NAVKARCORP, NIACL, NITINSPIN, PEL, *PETRONET*, PRUDENT, RAILTEL, REFEX, *SUMICHEM*, SUNDRMFAST, *TATASTEEL*, UDS, *UNIONBANK*, WELSPLSOL, WONDERLA, YATHARTH

*ACC* YoY
* Revenue expected at Rs 2980 crore versus Rs 2732 crore
* EBITDA expected to be seen at Rs 977 crore versus Rs 869 crore
* EBITDA margin expected to be seen at 32.79% versus 31.81%
* Net profit expected to be seen at Rs 512 crore versus Rs 355 crore

*CANBK* YoY
* NII expected at Rs 5681 crore versus Rs 4911 crore
* EBIT expected to be seen at Rs 4312 crore versus Rs 3689 crore
* EBIT margin expected to be seen at 74.81% versus 70.74%
* Net profit expected to be seen at Rs 2564 crore versus Rs 1818 crore

*COALINDIA* YoY
* Revenue expected at Rs 34762 crore versus Rs 36154 crore
* EBITDA expected to be seen at Rs 11743 crore versus Rs 11373 crore
* EBITDA margin expected to be seen at 33.78% versus 31.46%
* Net profit expected to be seen at Rs 8467 crore versus Rs 9069 crore

*IGL* QoQ
* Revenue expected at Rs 3946 crore versus Rs 3697 crore
* EBITDA expected to be seen at Rs 550 crore versus Rs 534 crore
* EBITDA margin expected to be seen at 13.94% versus 14.47%
* Net profit expected to be seen at Rs 355 crore versus Rs 454 crore

*IOC* QoQ
* Revenue expected at Rs 179959 crore versus Rs 174976 crore
* EBITDA expected to be seen at Rs 13762 crore versus Rs 3467 crore
* EBITDA margin expected to be seen at 7.65% versus 1.98%
* Net profit expected to be seen at Rs 3995 crore versus Rs -1326 crore

*PETRONET* QoQ
* Revenue expected at Rs 12593 crore versus Rs 13021 crore
* EBITDA expected to be seen at Rs 1272 crore versus Rs 1200 crore
* EBITDA margin expected to be seen at 10.10% versus 9.21%
* Net profit expected to be seen at Rs 892 crore versus Rs 847 crore

*SUMICHEM* YoY
* Revenue expected at Rs 638 crore versus Rs 542 crore
* EBITDA expected to be seen at Rs 127 crore versus Rs 65 crore
* EBITDA margin expected to be seen at 19.91% versus 12.14%
* Net profit expected to be seen at Rs 104 crore versus Rs 54 crore

*TATASTEEL* QoQ
* Revenue expected at Rs 52976 crore versus Rs 55311 crore
* EBITDA expected to be seen at Rs 4708 crore versus Rs 6263 crore
* EBITDA margin expected to be seen at 8.89% versus 11.32%
* Net profit expected to be seen at Rs -517 crore versus Rs 847 crore

*UNIONBANK* YoY
* NII expected at Rs 9192 crore versus Rs 9168 crore
* EBIT expected to be seen at Rs 7212 crore versus Rs 7277 crore
* EBIT margin expected to be seen at 55.73% versus 56.23%
* Net profit expected to be seen at Rs 4008 crore versus Rs 3589 crore

Stocks Picker Articles

28 Jan 2025 03:28

*Fund Houses Recommendations*


UBS on *Siemens:* Upgrade to Buy on company, target price at Rs 8000/Sh (Positive)

Nomura on *Balkrishna:* Upgrade to Buy on company, target price at Rs 3242/Sh (Positive)

Jefferies on *DLF:* Maintain Buy on Company, target price at Rs 1000/Sh (Positive)

Citi on *IGL:* Maintain Buy on Company, target price at Rs 450/Sh (Positive)

MS on *Coal India:* Maintain Overweight on Company, target price at Rs 525/Sh (Positive)

MOSL on *Coal India:* Maintain Buy on Company, target price at Rs 480/Sh (Positive)

Jefferies on *Coal India:* Maintain Buy on Company, target price at Rs 475/Sh (Positive)

MS on *Coal India:* Maintain Overweight on Company, target price at Rs 525/Sh (Positive)

MS on *Bajaj Fin:* Maintain Overweight on Company, target price at Rs 9000/Sh (Positive)

JP Morgan on *Tata Steel:* Maintain Overweight on Company, target price at Rs 155/Sh (Positive)

Jefferies on *Tata Steel:* Maintain Buy on Company, target price at Rs 160/Sh (Positive)

MS on *Tata Steel:* Maintain Equal weight on Company, target price at Rs 160/Sh (Positive)

MS on *ACC:* Maintain Equal weight on Company, target price at Rs 2510/Sh (Positive)

CLSA on *ACC:* Maintain Outperform on Company, target price at Rs 2580/Sh (Positive)

Investec on *JK Cement:* Maintain Buy on Company, target price at Rs 5147/Sh (Positive)

Investec on *Consumer Goods:* Rural growth outpaces urban, healthy jewelry demand, apparel strong post festive season (Positive)

Investec on *Industrials:* Govt and PSU orders steady, *L&T* benefits, budget insights to guide infra spending (Positive)

CLSA on *ACC:* Maintain Outperform on Company, target price at Rs 2580/Sh (Neutral)

Nomura on *ACC:* Maintain Reduce on Company, target price at Rs 1920/Sh (Neutral)

Investec on *ACC:* Maintain Hold on Company, target price at Rs 2845/Sh (Neutral)

Jefferies on *IOCL:* Maintain Buy on Company, cut target price at Rs 170/Sh (Positive)

Citi on *Petronet:* Maintain Sell on Company, target price at Rs 310/Sh (Positive)

MS on *Petronet:* Maintain Equal weight on Company, target price at Rs 400/Sh (Positive)

Macquarie on *Petronet:* Maintain Underperform on Company, target price at Rs 260Sh (Neutral)

Citi on *PEL:* Maintain Sell on Company, target price at Rs 800/Sh (Positive)

JP Morgan on *Coal India:* Maintain Neutral on Company, target price at Rs 435/Sh (Neutral)

MS on *Canara Bank:* Maintain Underweight on Bank, target price at Rs 80/Sh (Neutral)

UBS on *Federal Bank:* Maintain Buy on Bank, cut target price at Rs 235/Sh (Neutral)

HSBC on *Bajaj Housing:* Maintain Reduce on Company, cut target price at Rs 90/Sh (Neutral)

Nuvama on *Balkrishna:* Maintain Buy on Company, cut target price at Rs 3300/Sh (Neutral)

HSBC on *Credit access Gramin:* Downgrade to Hold on Company, cut target price at Rs 810/Sh (Negative)

Stocks Picker Articles

27 Jan 2025 16:06

Newgen Software Technologies Ltd Concall Notes - Jan 2025

Q3 FY'25 Performance Overview:

Revenue for the quarter reached INR 381 crores, reflecting an 18% Y-o-Y growth.

Geographic performance:

APAC: Highest growth at 44% Y-o-Y.

EMEA: Grew by 19% Y-o-Y.

India: Revenue growth of 10% Y-o-Y.

U.S.: Grew by 13% Y-o-Y.

Significant increase in license sales, achieving a 70% Y-o-Y growth.
Annuity revenues totaled INR 208 crores.

Longer execution cycles due to increased complexity in projects, some exceeding one year.

Key Wins and Contracts:

Secured a contract from RBI for the Regulatory Application Management System worth INR 32 crores.

Agreement with Aye Finance Limited for loan origination valued at INR 24 crores.

Saudi Arabia: Contract worth $2.3 million with a major power generation company.

Singapore: Providing a Knowledge and Records Management System valued at SGD 1.7 million.

U.S.: Working with a banking client for digital account opening and upgrades totaling $1.8 million.

Added 15 new logos in Q3, totaling 36 new logos over the past nine months.

Industry Insights:

Continued strong traction in banking and financial services; however, increasing interest in the government segment.

New generation NBFCs are poised to invest in the market to gain market share, compensating for weaker deposit growth in traditional banking.

Focus on AI and data science embedded in core products contributing to successful bids, particularly with financial institutions.

Product and Market Development:

Launched an AI-enabled captive finance solution to transform lending and leasing operations.

Expanding efforts in insurance and healthcare, with ongoing deals in mature markets.

Recognized as a niche player in the Gartner Magic Quadrant for Enterprise Low-Code Application Platforms (2024) and acknowledged in Forrester's landscape report.

Certified as a Great Place to Work in India, enhancing employee experience and workplace culture.

Financial Performance:

Profit after tax stood at INR 89 crores, a 30% Y-o-Y growth.

Nine-month revenue totaled INR 1,057 crores, with a 22% growth;

profit after tax at INR 207 crores, a 41% growth.

R&D expenses constituted 9% of revenues; sales and marketing expenses were at 22%.

Net trade receivables were INR 463 crores with a net DSO of 118 days.

Challenges and Outlook:

Management noted a potential short-term disruption in digital lending projects due to deposit growth weaknesses but remains optimistic about long-term prospects.

Expectation of continued growth in banking and insurance sectors, with a target to maintain above 20% growth in the long term.

Anticipated improvements in implementation revenue as new short-cycle deals are executed.

Margin Guidance:

Strong profit growth and margin expansion noted; margins expected to remain robust in Q4, with a target of around 20% net margin.

The company aims to maintain a balance between growth investments and margin improvements.

Future Strategy:

Continued focus on new deal wins and strengthening relationships with existing customers.

Investing in capabilities around AI, Gen AI, and machine learning to enhance operational efficiency and product offerings.

Commitment to developing a global workforce and improving operational efficiency as part of the growth strategy.

Stocks Picker Articles

27 Jan 2025 10:19

SUMITOMO CHEMICALS Q3 YOY

NET PROFIT AT 87 CR V 55 CR

REVENUE AT 641 CR v 540 Cr

EBITDA AT 106 CR V 66 CR

MARGINS AT 16.5 % V 12.2 %

Stocks Picker Articles

27 Jan 2025 08:48

ADANI WILMAR Q3 CONS

NET PROFIT 4.1B RUPEES VS 2B (YOY)

EBITDA 7.91B RUPEES VS 5.04B (YOY)

EBITDA MARGIN 4.69% VS 3.90% (YOY)

BIG BEAT YOY AND QOQ

Stocks Picker Articles

27 Jan 2025 08:05

JSW Steel says

👉 Steel prices have bottomed out

👉 Expect EBITDA/tn to improve in Q4 vs Q3

🤞 Industry is hopeful of some protection by the first half of February

Stocks Picker Articles

27 Jan 2025 07:02

Index down from Their ATH.

Nifty 🔻12.4%
MidCap_100 🔻14.1%
Smallcap_100 🔻14.8%
Auto 🔻20%
Infra 🔻15.1%
PSE 🔻23.3%
CPSE 🔻22.3%
Metal  🔻19.1%
Energy  🔻25.6%
Reality 🔻25.6%
PSU Bank🔻 23.3%
Bank Nifty 🔻12%
Sensex 🔻11.3%
FMCG 🔻15.8%
Pharma  🔻8.73%
IT 🔻5.5%

Stocks Picker Articles

27 Jan 2025 04:15

*Forthcoming Event*

27th January: AURIONPRO, COALINDIA, EMAMILTD, EPIGRAL, GTV, LTFOODS, MANBA, WEALTH, WHEELS to consider Dividend; 360 One Wam, Apollo Pipes, Biocon, Premier Energy & Infrastructure, Virinchi to consider Fund Raising; Lucent Industries to consider Scheme of Arrangement; Enbee Trade & Finance to consider Dividend & Bonus issue; Prime Securities to consider Buyback

28th January: APCOTEXIND, GESHIP, IIFLCAPS, IMPAL, JUBLINGREA, KIRLPNU, MGL, MOTILALOFS, RADIOCITY, RITES, ROUTE, SHAREINDIA, SHYAMMETL, STEELCAS to consider Dividend; Dhruva Capital Services, Home First Finance Company India, JostS Engineering Company, JSW Energy, Lasa Supergenerics, Swagtam Trading & Services, Thirumalai Chemicals to consider Fund Raising; JTL Industries to consider Voluntary Delisting

29th January: AARTIDRUGS, CAMS, IMFA, JSL, KPITTECH, MASFIN, ORIENTELEC, QUESS, SMCGLOBAL, SRF, VAIBHAVGBL, WEL to consider Dividend

30th January: BANARBEADS, CLEAN, CONCOR, GAIL, LALPATHLAB, SHANTIGEAR, SHREECEM to consider Dividend; Shivamshree Business to consider Fund Raising

31st January: CHOLAFIN, INDTONER, MARICO, NESTLEIND, ONGC, SUNPHARMA, TRITURBINE to consider Dividend; Poonawalla Fincorp to consider Fund Raising

03rd February: CASTROLIND, GRSE, KPRMILL, TIINDIA to consider Dividend

04th February: GPTINFRA to consider Dividend; Happiest Minds Technologies to consider Scheme of Arrangement

05th February: CUMMINSIND, PAGEIND, VRLLOG to consider Dividend

06th February: BDL, GULFOILLUB, PIIND to consider Dividend; Aadhar Housing Finance to consider Fund Raising

07th February: FSL, GOLDIAM to consider Dividend

08th February: Exxaro Tiles to consider Fund Raising

10th February: CRISIL, ESABINDIA to consider Dividend

12th February: SUPRAJIT to consider Dividend; Muthoot Finance to consider Fund Raising

13th February: Bal Pharma to consider Fund Raising

Stocks Picker Articles

27 Jan 2025 04:15

*OPENING BELL* 🗞

*Date: 27-Jan-2025*

📍 1. Order Wins & Contract Updates

- KEC International: Secured new orders worth ₹1,445 crores in the Transmission & Distribution (T&D) segment.

- RPP Infra Projects: Awarded an ₹87.56 crore order for constructing stormwater drains in Tamil Nadu.

- Newmalayalam Steel: Received orders worth ₹5.69 crore for supplying pipes and tubes.

- Lakshaya Powertech: Won an order of ₹1.36 crore for the supply and installation of DG sets.

- Kailash Exports: Received export orders worth ₹55 crore.

- L&T Technology Services: Secured new contracts valued at ₹2,200 crore for engineering solutions.

- BHEL: Awarded a ₹275 crore order for setting up power plants in a foreign market.

---

📍 2. Q3 Financial Results / Updates

- RPG Life Sciences: Achieved a 32% YoY growth in net profit, which stood at ₹34.9 crore.

- Steel Exchange India: Saw a dramatic 7830% YoY surge in net profit to ₹15.85 crore.

- SBC Exports: Net profit increased by 25% YoY to ₹3.57 crore.

- Mehai Technology: Reported a 581% QoQ rise in net profit, amounting to ₹5.45 crore.

- Cybertech Systems: Achieved a 64% YoY increase in net profit to ₹9.04 crore.

- Surana Solar: Registered a 60% YoY rise in net profit to ₹0.16 crore.

- JK Cement: Reported a 33% YoY decline in net profit, amounting to ₹189 crore.

- Macrotech Developers: Reported an 88% YoY increase in net profit, details unspecified.

- L&T Finance: Reported a 20% YoY growth in profit during the quarter.

---

📍 3. Acquisitions & Mergers

- Equinox India: Completed its merger with the Embassy Group to strengthen its real estate portfolio.

- Gujarat Ambuja Exports: Acquired 50 lakh equity shares in Maiz Citchem Ltd., making it a subsidiary.

- Palco Metals: Acquired full ownership of Palco Recycle Industries Ltd., enhancing its metal recycling operations.

- Jubilant Pharmova: Completed a strategic acquisition of a manufacturing facility in Europe.

- Hindustan Zinc: Acquired a 5% stake in a zinc mining company in Africa.

- Suzlon Energy: Finalized the acquisition of a wind turbine manufacturing facility in the U.S.

---

📍 4. Leadership Changes & Appointments

- Equinox India: Appointed Mr. Jitendra Mohandas Virwani as a Non-Executive Non-Independent Director.

- L&T Finance: Mr. Sanjay Garyali, the Chief Executive of Urban Finance, will resign in March 2025.

- Motherson Sumi Systems: Appointed a new CEO to lead its global expansion initiatives.

- HDFC Bank: Announced the appointment of a new Chief Risk Officer to enhance governance.

- Tata Motors: Appointed a new Director for Electric Vehicles and Sustainable Mobility.

---

📍 5. New Projects, Expansion & Facilities

- Lemon Tree Hotels: Signed a memorandum of agreement for a new hotel in Gujarat, set to open in FY 2029.

- Kody Technolab: Launched Falcon Tech Robotics LLC in partnership with Platinum Group in the UAE.

- Tech Mahindra: Began work on a new AI-based data center project in California.

- ICICI Bank: Expanded its branch network with the opening of 50 new branches across India.

- Hindalco: Announced the construction of a new aluminum processing plant in Jharkhand.

- Asian Paints: Set to expand its manufacturing plant in Gujarat for enhanced production capacity.

---

📍 6. Legal / Regulatory & Compliance Updates

- Jubilant Foodworks: Received a GST demand order amounting to ₹14.57 crore for discrepancies.

- PC Jewellers: Filed a settlement application with SEBI regarding ongoing regulatory proceedings.

- Yes Bank: Received a directive from RBI to enhance risk management protocols.

- ICICI Lombard: Settled a regulatory investigation into mis-selling insurance policies, agreeing to a fine.

- Adani Ports: Settled a dispute with the Gujarat Maritime Board concerning land use regulations.

---

📍 7. Corporate Strategy & Restructuring

- Mehai Technology: Approved a stock split of 1 share into 10 shares, aimed at improving liquidity and accessibility for investors.

Stocks Picker Articles

27 Jan 2025 04:00

Bulk Deal & Insider Trade Update*

*Bulk Deals*
*Pelatro Limited: Sb Opportunities Fund I Sell 60000 Shares @ Rs. 395.04
*Happyforge: Business Excellence Trust Iii Sell 3910098 Shares @ Rs. 950.06
*Happyforge: Sbi Mutual Fund Buy 3591766 Shares @ Rs. 950
*Aarnav: Chanakya Opportunities Fund I Buy 250000 Shares @ Rs. 73.58

*Insider Trade*
---

*Dividend Update*
*KEI Industries Ltd.: Interim Dividend Rs. 4.00; Ex Date: 27-Jan-2025
*Tanla Platforms Ltd.: Interim Dividend Rs. 6.00; Ex Date: 27-Jan-2025

*Result Today*
Coal India Ltd.
Indian Oil Corporation Ltd.
Tata Steel Ltd.
Bajaj Housing Finance Ltd.
Union Bank Of India
Canara Bank
Adani Total Gas Ltd.
360 One Wam Ltd.
Petronet LNG Ltd.
The New India Assurance Company Ltd.
Sumitomo Chemical India Ltd.
Emami Ltd.
Piramal Enterprises Ltd.
Aditya Birla Sun Life AMC Ltd.
Sundram Fasteners Ltd.
Aurionpro Solutions Ltd.
Maharashtra Seamless Ltd.
Epigral Ltd.
Wonderla Holidays Ltd.
Mahindra Logistics Ltd.
Nitin Spinners Ltd.
Navkar Corporation Ltd.
Jindal Drilling & Industries Ltd.
Apollo Pipes Ltd.
Wealth First Portfolio Managers Ltd.
Premier Polyfilm Ltd.
Manba Finance Ltd.
Lehar Footwears Ltd.
Golden Crest Education & Services Ltd.
Rossell India Ltd.
DHP India Ltd.
Asit C Mehta Financial Services Ltd.

Stocks Picker Articles

27 Jan 2025 03:55

*Go Fashion:* Net profit at Rs 24.3 cr vs Rs 23.4 cr, Revenue at Rs. 214.0 cr vs Rs 202.0 cr (YoY). (Neutral)

*Ador welding:* Net profit at Rs 15.4 cr vs Rs 18.7 cr, Revenue at Rs. 274 cr vs Rs 261 cr (YoY). (Neutral)

*Trident:* Net profit at Rs 80 cr vs Rs 109 cr, Revenue at Rs. 1667 cr vs Rs 1835 cr (YoY) (Neutral)

*Sasken:* Net profit at Rs 8.2 cr vs Rs 17.9 cr, Revenue at Rs. 144.0 cr vs Rs 96.0 cr (YoY) (Neutral)

*GRP:* Net profit at Rs 4.4 cr vs Rs 4.3 cr, Revenue at Rs. 142 cr vs Rs 118 cr (YoY) (Neutral)

*IDFC First:* Net Profit At ₹339.4 Cr Vs ₹715.7 Cr, NII At ₹4,902 Cr Vs ₹4,286.6 Cr (YoY) (Neutral)

*ICICI Bank:* Net profit at Rs 11792 crore versus poll of Rs 11333 crore, NII at Rs 20371 crore versus poll of Rs 20461 crore (Neutral)

*CDSL:* Net profit at Rs 130.0 crore versus Rs 107.0 crore YoY, Rs 162.0 Cr QoQ. Revenue at Rs 278.0 crore versus Rs 214.0 crore YoY, Rs 322.0 Cr QoQ (Neutral)

*Meghna Infracon:* Company announced the resignation of its Chief Executive Officer, Mr. Sanjeev Roshan Bansal, effective January 24,2025. (Neutral)

*LTIMindtree:* Company announces Venu Lambu as CEO designate. (Neutral)

*Zydus Wellness:* Company subsidiary received a Rs 9.35 million penalty order from Punjab authorities for alleged tax short payment (FY 2017-18) (Neutral)

*LTIMindtree:* Company announced the closure of its wholly-owned subsidiary, LTIMindtree LLC, in the USA, effective January 21, 2025. (Neutral)

*Jupiter Wagons:* Jupiter electric mobility and porter unite to sign a MOU to empower drivers through Jem Udaan program. (Neutral)

*C.E. Info Systems:* Acquires a stake in Simdaas Autonomy Private Limited for a consideration of ₹2.9 crores. (Neutral)

*JK Cement:* Net Profit At ₹189.6 Cr Vs ₹283.8 Cr, Revenue At ₹2,930.3 Cr Vs ₹2,934.8 Cr (YoY) (Negative)

*CreditAccess:* Revised loan growth guidance from 23%-24% to 8%-12% in October 2024 to now 7%-8% (Negative)

*One Mobikwik:* Resignation announced from Chandan Joshi, Co-Founder & CEO, Payments Division. (Negative)

*AU Small Bank:* FY25 Loan Growth Guidance Cut To 20% from Earlier Guidance Of 25% (Negative)

*IndiGo:* Net profit at Rs 2449 cr vs poll Rs 3152 cr, Revenue at Rs. 22,111 cr vs poll Rs 22,241 cr (Negative)

*Orient Cement:* Net profit at Rs 10 cr vs Rs 45 cr, Revenue at Rs. 643 cr vs Rs 751 cr (YoY) (Negative)

*Sagar Cement:* Net loss at Rs 54.5 cr vs Rs 10.5 cr, Revenue at Rs. 563 cr vs Rs 669 cr (YoY) (Negative)

*Suryoday Small Finance:* Net Profit at Rs 33.3 Cr Vs Rs 57.2 Cr, NII Up at Rs 268.3 Cr Vs Rs 245.7 Cr (YoY) (Negative)

*Fino Payment Bank:* Disclosure of fraud involving ₹35.5 crore and employee actions. (Negative)

Stocks Picker Articles

25 Jan 2025 09:13

*TATASTEEL* QoQ
* Revenue expected at Rs 52976 crore versus Rs 55311 crore
* EBITDA expected to be seen at Rs 4708 crore versus Rs 6263 crore
* EBITDA margin expected to be seen at 8.89% versus 11.32%
* Net profit expected to be seen at Rs -517 crore versus Rs 847 crore

*UNIONBANK* YoY
* NII expected at Rs 9192 crore versus Rs 9168 crore
* EBIT expected to be seen at Rs 7212 crore versus Rs 7277 crore
* EBIT margin expected to be seen at 55.73% versus 56.23%
* Net profit expected to be seen at Rs 4008 crore versus Rs 3589 crore

Stocks Picker Articles

25 Jan 2025 09:12

*CDSL Q3*

Net profit at Rs 130.0 crore versus Rs 107.0 crore YoY, Rs 162.0 Cr QoQ

Revenue at Rs 278.0 crore versus Rs 214.0 crore YoY, Rs 322.0 Cr QoQ

(YoY performance seen northward, however QoQ performance has seen lower for the first time since FY23)

Stocks Picker Articles

24 Jan 2025 04:31

Forthcoming Event

24th January: GODREJCP, GOTHIPL, SHARDACROP, TORNTPHARM to consider Dividend; Padam Cotton Yarns to consider Bonus issue; Shriram Finance to consider Dividend & Fund Raising; Mehai Technology to consider Fund Raising & Stock Split

25th January: BALKRISIND, JGTL, TCI to consider Dividend

27th January: COALINDIA, EMAMILTD, EPIGRAL, MANBA, WEALTH to consider Dividend; Biocon, 360 One Wam to consider Fund Raising

28th January: JUBLINGREA, RADIOCITY, RITES, GESHIP to consider Dividend; Home First Finance Company India to consider Fund Raising

29th January: CAMS, VAIBHAVGBL to consider Dividend

30th January: BANARBEADS, CONCOR, SHREECEM to consider Dividend

31st January: MARICO, ONGC, SUNPHARMA to consider Dividend

03rd February: CASTROLIND to consider Dividend

05th February: CUMMINSIND, PAGEIND to consider Dividend

06th February: GULFOILLUB to consider Dividend; Aadhar Housing Finance to consider Fund Raising

Stocks Picker Articles

24 Jan 2025 03:27

Stocks in Action

Pidilite Industries : The Company is India’s leading manufacturer of adhesives, sealants and construction chemicals. The company posted healthy results for the quarter ended Q3FY25 with net sales growing by grew by 9% YoY to Rs 3,357 cr (excluding Pidilite USA and Pulvitec Brazil) .Net sales for the nine months stood at Rs 9,964 cr and grew by 7% YoY (excluding Pidilite USA and Pulvitec Brazil).EBITDA before non-operating income at Rs 798 cr growing by 8% YoY. EBITDA for the nine months stood at Rs 2,380 cr and grew by 12% YoY. Profit before Tax and Exceptional Items (PBT) at Rs 752 cr growing by 9% YoY. PBT for the nine months stood at Rs 2,247 cr and grew by 15% YoY. Profit after Tax (PAT) came at Rs 557 cr growing by 9% YoY. PAT for the nine months stood at Rs 1,669 cr and growing by 16% YoY. The current quarter’s revenue growth of 9.3% was aided by UVG of 9.7% across categories and geographies. Consumer and Bazaar (‘C&B’) UVG was 7.3%, while Business to Business (‘B2B’) maintained growth momentum with UVG of 21.7%. Gross Margins improved by 100 bps year on year, primarily due to benign input prices. With stepped up A&SP spends, EBITDA Margins were 24.3% as compared to 25.1% in Q3FY24. For nine months of the current financial year, UVG was 9.2% with C&B UVG of 7.0% and B2B UVG of 20.2%. Gross Margins improved by 284 bps over previous year, on account of lower input costs. EBITDA Margins were 24.5%, compared to 23.7% in previous year. Company continues to invest in brand building, upgrading and building new manufacturing facilities and expanding distribution network. Innovation across C&B and B2B segment continued to be a significant contributor to the overall revenues of the company. Positive on Pidilite Industries given the strong fundamentals and performance of the company.

Marico : The company is one of India's leading consumer goods companies operating in global beauty and wellness categories. It is present in over 25 countries across emerging markets of Asia and Africa. It nurtures leading brands across categories of hair care, skin care, edible oils, healthy foods, male grooming and fabric care. Marico’s Q2FY2025 performance was largely in line with expectations, with consolidated revenues growing by 8% YoY to Rs 2,664 cr (India biz volumes grew 5%YoY) and OPM declining marginally by 48 bps YoYto 19.6%, PAT grew by 20% YoY to Rs 433 cr . Marico hiked Parachute prices by 4% in Q2, while Saffola oils saw a price increase of 15%, flow though for both is expected in H2. For Saffola, the company plans to maintain certain level of margin for the oils portfolio and will continue to strongly grow the foods portfolio. The company aims to grow foods at 20-25% CAGR to 2x of FY24 revenues in FY27. The Digital-first portfolio is expected to exit FY25 at an ARR of Rs. 600 crore and scale to 2x of FY24 ARR in FY27. It aims to increase the share of foods and premium personal care portfolios to 25% by FY2027 from 21% in H1FY2025. Š Beardo and Plix are expected to grow to Rs. 500 crore ARR each in next 3years. Beardo is on track to post double-digit EBITDA margin in FY2025. In the international market, Marico aims to maintain the double-digit constant currency growth momentum over the medium term, with focus on 20-25% growth in the non-Bangladesh regions. Going ahead Management expects volume growth to sequentially improve in the quarters ahead. Revenue growth will improve to double digits with pricing growth expected to further improve in H2. Company eyes double-digit growth in FY2025. Positive on Marico given the strong fundamentals and performance of the company.

Stocks Picker Articles

24 Jan 2025 03:16

*Q3FY25 Earning Calendar - 24.01.2025*

ADORWELD, ALKYLAMINE, ARKADE, ASALCBR, ATUL, *AUBANK*, BANKINDIA, BIRLAMONEY, CENTRUM, CREDITACC, DAMCAPITAL, DCBBANK, *DLF*, EMSLIMITED, FEDFINA, GARGI, *GODREJCP*, GRANULES, GREENPOWER, GRPLTD, *INDIGO*, INTELLECT, JINDALSAW, *JSWSTEEL*, LAURUSLABS, LMW, NIITLTD, ORIENTCEM, POCL, RPGLIFE, SAGCEM, SASKEN, SHAKTIPUMP, SHARDACROP, SHREDIGCEM, *SHRIRAMFIN*, SOLARA, STEELXIND, SUPRIYA, SUVEN, TANFACIND, *TORNTPHARM*, TOTEM, TRIDENT, TTKHLTCARE, UGROCAP, VIMTALABS, VISHNU

*AUBANK* YoY
* NII expected at Rs 2026 crore versus Rs 1324 crore
* EBIT expected to be seen at Rs 1106 crore versus Rs 657 crore
* EBIT margin expected to be seen at 41.86% versus 49.60%
* Net profit expected to be seen at Rs 520 crore versus Rs 375 crore

*DLF* YoY
* Revenue expected at Rs 1707 crore versus Rs 1521 crore
* EBITDA expected to be seen at Rs 668 crore versus Rs 504 crore
* EBITDA margin expected to be seen at 39.13% versus 33.19%
* Net profit expected to be seen at Rs 1128 crore versus Rs 656 crore

*GODREJCP* YoY
* Revenue expected at Rs 3719 crore versus Rs 3659 crore
* EBITDA expected to be seen at Rs 772 crore versus Rs 840 crore
* EBITDA margin expected to be seen at 20.76% versus 22.97%
* Net profit expected to be seen at Rs 526 crore versus Rs 588 crore

*INDIGO* YoY
* Revenue expected at Rs 22241 crore versus Rs 19452 crore
* EBITDA expected to be seen at Rs 6491 crore versus Rs 5149 crore
* EBITDA margin expected to be seen at 29.18% versus 26.47%
* Net profit expected to be seen at Rs 3842 crore versus Rs 2998 crore

*JSWSTEEL* YoY
* Revenue expected at Rs 40749 crore versus Rs 41940 crore
* EBITDA expected to be seen at Rs 4994 crore versus Rs 7180 crore
* EBITDA margin expected to be seen at 12.26% versus 17.12%
* Net profit expected to be seen at Rs 618 crore versus Rs 2415 crore

*SHRIRAMFIN* YoY
* NII expected at Rs 5681 crore versus Rs 4911 crore
* EBIT expected to be seen at Rs 4312 crore versus Rs 3689 crore
* EBIT margin expected to be seen at 74.81% versus 70.74%
* Net profit expected to be seen at Rs 2564 crore versus Rs 1818 crore

*TORNTPHARM* YoY
* Revenue expected at Rs 2980 crore versus Rs 2732 crore
* EBITDA expected to be seen at Rs 977 crore versus Rs 869 crore
* EBITDA margin expected to be seen at 32.79% versus 31.81%
* Net profit expected to be seen at Rs 512 crore versus Rs 355 crore


*Q3FY25 Earning Calendar - 25.01.2025*
APTECHT, *BALKRISIND*, GAEL, GOCOLORS, *ICICIBANK*, *IDFCFIRSTB*, INDOTHAI, JKCEMENT, *LODHA*, *NTPC*, NTPCGREEN, SBFC, SIYSIL, SPORTKING, TCI, *YESBANK*

*BALKRISIND* YoY
* Revenue expected at Rs 2515 crore versus Rs 2274 crore
* EBITDA expected to be seen at Rs 614 crore versus Rs 540 crore
* EBITDA margin expected to be seen at 24.41% versus 23.77%
* Net profit expected to be seen at Rs 383 crore versus Rs 305 crore

*ICICIBANK* QoQ
* NII expected at Rs 20588 crore versus Rs 20048 crore
* EBIT expected to be seen at Rs 16846 crore versus Rs 16723 crore
* EBIT margin expected to be seen at 81.73% versus 83.42%
* Net profit expected to be seen at Rs 11540 crore versus Rs 11745 crore

*IDFCFIRSTB* QoQ
* NII expected at Rs 4972 crore versus Rs 4788 crore
* EBIT expected to be seen at Rs 1971 crore versus Rs 1961 crore
* EBIT margin expected to be seen at 29.31% versus 30.11%
* Net profit expected to be seen at Rs 426 crore versus Rs 200 crore

*LODHA* YoY
* Revenue expected at Rs 3170 crore versus Rs 2930 crore
* EBITDA expected to be seen at Rs 791 crore versus Rs 882 crore
* EBITDA margin expected to be seen at 24.95% versus 30.12%
* Net profit expected to be seen at Rs 494 crore versus Rs 608 crore

*NTPC* YoY
* Revenue expected at Rs 45441 crore versus Rs 42820 crore
* EBITDA expected to be seen at Rs 12945 crore versus Rs 11362 crore
* EBITDA margin expected to be seen at 28.49% versus 26.53%
* Net profit expected to be seen at Rs 5217 crore versus Rs 5155 crore